New York biotech company trades $60 million in stock for CBD group
New York-based biotech company 22nd Century Group, Inc. said it has started integration with GVB Biopharma after swapping $60-65 million in stock for 100% of the Las Vegas-based CBD company […]
New York biotech company trades $60 million in stock for CBD group Read More »